IMMUNOHISTOCHEMISTRY, THYROGLOBULIN

The IHC – Thyroglobulin test is an immunohistochemistry-based diagnostic assay used to detect thyroglobulin protein expression in tissue samples. Thyroglobulin is a glycoprotein produced almost exclusively by the follicular cells of the thyroid gland and serves as a highly specific marker for thyroid tissue.

This test is widely used in surgical pathology and oncology to identify tumors of thyroid origin. It helps pathologists diagnose and classify thyroid cancers, including papillary thyroid carcinoma and follicular thyroid carcinoma, and distinguish them from non-thyroid malignancies. The test is also valuable in evaluating metastatic tumors when the primary site is uncertain.

By demonstrating thyroglobulin expression within tumor cells, the IHC Thyroglobulin test helps confirm thyroid differentiation and supports accurate diagnosis, prognosis assessment, and treatment planning.

Benefits of the Test

• Helps identify thyroid-origin tumors
• Assists in diagnosing thyroid cancer
• Supports classification of thyroid neoplasms
• Helps differentiate thyroid tumors from other cancers
• Assists in identifying metastatic thyroid carcinoma

Why Doctors Recommend This Test

Doctors recommend the IHC Thyroglobulin test when evaluating thyroid nodules, thyroid tumors, or metastatic lesions suspected to originate from the thyroid gland. It is commonly used in:

• Papillary thyroid carcinoma diagnosis
• Follicular thyroid carcinoma evaluation
• Thyroid tumor classification
• Metastatic cancer origin identification
• Oncology biopsy interpretation
• Endocrine pathology investigations

Thyroglobulin is frequently used alongside markers such as TTF-1, CK19, HBME-1, Galectin-3, PAX8, and Calcitonin to provide comprehensive thyroid tumor profiling.

Preparation Before Test

No special preparation is required for this test. Important considerations include:

• The test is performed on a biopsy or surgical tissue sample
• No fasting is required
• No medication restrictions are generally necessary
• Clinical history, imaging studies, and pathology findings may assist interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on specimen processing and laboratory workflow.

Who Should Take This Test

• Patients with suspected thyroid cancer
• Individuals with thyroid nodules requiring pathological evaluation
• Patients with metastatic tumors of unknown origin
• Cases requiring thyroid tumor classification
• Oncology and endocrine patients requiring immunohistochemistry profiling

The IHC Thyroglobulin test is an important diagnostic tool in endocrine pathology. By identifying thyroid-specific protein expression, it helps clinicians accurately diagnose thyroid tumors and determine the origin of metastatic lesions.

Clinical Significance

Thyroglobulin immunostaining is commonly used in the evaluation of:

• Papillary thyroid carcinoma
• Follicular thyroid carcinoma
• Differentiated thyroid cancer
• Metastatic thyroid carcinoma
• Thyroid follicular neoplasms
• Thyroid-origin tumors

Strong cytoplasmic thyroglobulin positivity is highly suggestive of thyroid follicular cell differentiation and is considered one of the most specific markers for thyroid tissue origin.